SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-002248
Filing Date
2024-01-09
Accepted
2024-01-09 15:03:20
Documents
12
Period of Report
2024-01-08
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea191413-8k_hoththera.htm   iXBRL 8-K 23662
  Complete submission text file 0001213900-24-002248.txt   198092

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE hoth-20240108.xsd EX-101.SCH 3039
3 XBRL LABEL FILE hoth-20240108_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE hoth-20240108_pre.xml EX-101.PRE 22375
6 EXTRACTED XBRL INSTANCE DOCUMENT ea191413-8k_hoththera_htm.xml XML 3406
Mailing Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020 551-578-2261
Hoth Therapeutics, Inc. (Filer) CIK: 0001711786 (see all company filings)

IRS No.: 821553794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38803 | Film No.: 24523007
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)